Highlights and Quick Summary
- Annual ROIC for 2022 was -5.03% (a -142.99% decrease from previous year)
- Annual ROIC for 2021 was 11.7% (a -26.42% decrease from previous year)
- Annual ROIC for 2020 was 15.9% (a 285.92% increase from previous year)
- Twelve month ROIC ending June 30, 2023 was -19.34% (a 105.31% increase compared to previous quarter)
- Twelve month trailing ROIC decreased by -513.25% year-over-year
Trailing ROIC for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -19.34% | -9.42% | -5.03% | 4.68% |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROIC of Emergent Biosolutions Inc.
Most recent ROICof EBS including historical data for past 10 years.Interactive Chart of ROIC of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. ROIC for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -5.03% |
| 2021 | – | – | – | – | 11.7% |
| 2020 | – | – | – | – | 15.9% |
| 2019 | – | – | – | – | 4.12% |
| 2018 | – | – | – | – | 3.31% |
| 2017 | – | – | – | – | 10.41% |
| 2016 | – | – | – | – | 11.12% |
| 2015 | – | – | – | – | 14.78% |
| 2014 | – | – | – | – | 10.64% |
| 2013 | – | – | – | – | 7.19% |
| 2012 | – | – | – | – | 5.16% |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic